Localized Radiation Therapy or Recombinant Interferon Beta and Anti-PD-L1 (Avelumab) With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Conditions:   Merkel Cell Polyomavirus Infection;   Stage IV Merkel Cell CarcinomaInterventions:   Drug: Anti-PD-L1 Monoclonal Antibody Avelumab;   Radiation: Radiation Therapy;   Biological: Recombinant Interferon Beta;   Biological: MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells;   Other: Laboratory Biomarker AnalysisSponsors:   Fred Hutchinson Cancer Research Center;   EMD Serono;   National Cancer Institute (NCI)Not yet recruiting - verified October 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials